Undertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset

To assess the gap between visual acuity (VA) outcomes with anti-vascular endothelial growth factor (anti-VEGF) therapies in clinical trials and real-world practice, and explore the reasons for this gap. The literature was searched from January 1, 2013, to June 30, 2018, for studies reporting VA gain...

Celý popis

Podrobná bibliografia

Vydané v:	Ophthalmologica (Basel) Ročník 243; číslo 1; s. 1
Hlavní autori:	Monés, Jordi, Singh, Rishi P, Bandello, Francesco, Souied, Eric, Liu, Xin, Gale, Richard
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland 2020
Predmet:	Anti-VEGF Undertreatment Neovascular age-related macular degeneration Treatment burden
ISSN:	1423-0267, 1423-0267
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!